4.8 Editorial Material

Rapamycin, anti-aging, and avoiding the fate of Tithonus

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 123, Issue 8, Pages 3204-3206

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI70800

Keywords

-

Funding

  1. NIA NIH HHS [RC2 AG036613] Funding Source: Medline

Ask authors/readers for more resources

The discovery that rapamycin increased the lifespan of mice was recognized by Science as one of the top 10 scientific breakthroughs of 2009. In addition to increasing lifespan, Neff and colleagues show that while rapamycin improves several functions/pathologies that change with age, it has little effect on the majority of the physiological and structural parameters they evaluated. What do these data tell us about the ability of rapamycin to delay aging and improve quality of life, i.e., prevent the fate of Tithonus?

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available